Advertisement
Advertisement
HIMS
Hims & Hers Health, Inc.
25.05
USDSponsored
+0.81
+3.34%
May 15, 15:59 UTC -4
Closed
After-Market
24.78
-0.27
-1.07%
HIMS Earnings Reports
Positive Surprise Ratio
HIMS beat 15 of 22 last estimates.
68%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$655.81M
/$0.11
Implied change from Q1 26 (Revenue/ EPS)
+7.84%
/-161.11%
Implied change from Q2 25 (Revenue/ EPS)
+20.37%
/-35.29%
Hims & Hers Health, Inc. earnings per share and revenue
On May 11, 2026, HIMS reported earnings of -0.18 USD per share (EPS) for Q1 26, missing the estimate of 0.04 USD, resulting in a -507.24% surprise. Revenue reached 608.10 million, compared to an expected 629.19 million, with a -3.35% difference. The market reacted with a -14.10% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of 0.11 USD, with revenue projected to reach 655.81 million USD, implying an decrease of -161.11% EPS, and increase of 7.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Doximity, Inc.
Report Date
May 13, 2026 For Q4 26
Estimate
$0.28
Actual
$0.26
Surprise
-9.97%
Heartflow, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.16
Surprise
+16.45%
CapsoVision, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
Nyxoah SA Ordinary Shares
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.36
Surprise
+27.56%
MDxHealth SA Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.19
Surprise
-22.58%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.28
Surprise
-4.99%
Neuraxis, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+7.12%
Health Catalyst, Inc Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
$0.01
Actual
$0.02
Surprise
+14.29%
Heartbeam, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+14.77%
P3 Health Partners Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$3.57
Actual
-$0.99
Surprise
+72.31%
FAQ
What were Hims & Hers Health, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Hims & Hers Health, Inc. reported EPS of -$0.18, missing estimates by -507.24%, and revenue of $608.10M, -3.35% below expectations.
How did the market react to Hims & Hers Health, Inc.'s Q1 2026 earnings?
The stock price moved down -14.1%, changed from $29.14 before the earnings release to $25.03 the day after.
When is Hims & Hers Health, Inc. expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Hims & Hers Health, Inc.'s next earnings report?
Based on 10
analysts, Hims & Hers Health, Inc. is expected to report EPS of $0.11 and revenue of $655.81M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement